In today’s feature article, we talk with Ziyad Al-Aly, MD, of the Institute for Public Health in Washington, DC, who describes treating long-haulers as “America’s next big health crisis.”
Excessive urination at night, or nocturia, is not uncommon in postmenopausal women. There are a number of treatment options available but with varying degrees of success.
Proton pump inhibitors are FDA-approved for gastroesophageal reflux disease, gastric ulcers and other conditions, but not type 2 diabetes.
Study authors assessed the long-term effectiveness and safety of GH in real-life clinical practice and whether age mattered at the time of treatment initiation.
This study was launched to analyze the effect of setmelanotide, a melanocortin 4 receptor agonist, on weight loss and hunger reduction in patients with obesity and a confirmed diagnosis of Bardet-Biedl syndrome (BBS) or Alströmsyndrome (AS).
